The Smartphone Psychiatrist

0
In this piece for The Atlantic, David Dobbs delves into the life of former NIMH director Thomas Insel, his critiques of research within the field of...

Antidepressants are Accumulating in Fish Brains in the Wild

0
From the International Business Times: Americans are taking so many antidepressants that they are showing up in wild fish. Ten different species of fish in...

Proove Biosciences Sells Off Assets as CEO Departs

0
From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...

Part V: The Michelle Carter Texting Trial Becomes a Witch Hunt

22
In Parts I-IV, I discuss how the DA succeeded in gaining the conviction by means of highly emotional and at times misleading and untruthful manipulations in public and in the courtroom. Here I want to look more closely at the DA’s motivation and other activities. Was it a personal vendetta?

Belief in a Favorable Future May Undermine that Future

0
People who are more likely to believe that others’ views will change to match their own over time are less likely to engage in actions to facilitate that change

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

0
From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

Researchers Question Add-On Treatment for ‘Schizophrenia’

12
A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.

Why Addiction Language is Harmful

0
In this video for Benzo Brains, Jocelyn Pedersen explains why addiction is harmful to benzodiazepine survivors and differentiates benzodiazepine associated disability (BAD) from benzodiazepine addiction.

Deprescribing: How to be on Less Medication for Healthier Aging

0
In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...

Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities

16
One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

The Real Opioid Emergency

0
From The New York Times: In recent years, politicians have shown increased awareness of the opioid epidemic and have made statements about the need for treatment,...

The Concept of Schizophrenia is Coming to an End – Here’s Why

6
From The Conversation: Many researchers are beginning to acknowledge that the concept of "schizophrenia" as a discrete, hopeless, and deteriorating brain disease does not exist. In...

Abilify: The Drug That Could Gamble Your Life Away

1
On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Pharma Responds: Antidepressants Really Work. Really?

74
A recent meta-analysis published in Molecular Psychiatry claims to have settled the debate on whether the slight superiority of antidepressants in trials is due to side effects breaking blind. The principle author was quoted as saying: "once and for all, we've answered the SSRI question." Have they?

Psychiatry’s Necessary Shadow: The Philosophy of Mental Illness

2
In this piece for Medium, Andrés Ruiz explores the reasons that psychiatry is the only medical speciality with an anti-movement and a history of sustained criticism....

Lithium

0
In this piece for Healing Journey, Anne O'Beirne briefly summarizes the history of the medical usage of lithium and describes the impact that the drug has...

Researchers Question the “Adequacy and Legitimacy” of ADHD Diagnosis

9
A new article, just published online in the journal Emotional and Behavioural Difficulties, presents research suggesting that the diagnosis of ADHD is philosophically inadequate.

FDA Seeks Input on Drug Risk Information in Broadcast Ads

0
From FDA in Brief: The FDA seeks input from consumers and medical professionals on making sure the drug risk information in statements included in direct-to-consumer...

Study Identifies Cause of Weight Gain From Antipsychotic Drugs

2
From UPI: A team of researchers from the University of Texas Southwestern Medical Center found that the serotonin 2c receptor is responsible for weight gain...

Vanda Puts Antipsychotic Side Effect Front and Center in TV Ads

0
From FiercePharma: Vanda Pharmaceuticals, which makes the antipsychotic drug Fanapt, has recently rolled out a national TV campaign to raise awareness of akathisia. The company...

Ethical Failings in Experimental Drug Safety Trials

1
Leading human subjects ethics researcher questions exploitation of uninsured minorities in experimental drug trials.

My Grandmother is a Drug Addict—and I Blame Big Pharma

0
In this piece for Alternet, Joshua Wilkey discusses his grandmother's addiction to opioid painkillers and details the role that pharmaceutical companies have played in Appalachia's opioid...

ADHD Diagnosis Based on “Illogical Rhetoric,” Analysis Claims

11
In a philosophically rigorous article, Spanish researcher Marino Pérez-Álvarez examines the logic of attention-deficit hyperactivity disorder (ADHD).

Psychiatry’s 12-Step Program for Producing Heroin Addicts

81
I believe that today’s heroin addicts are a new breed — the seeds of their creation were sown back in 1990, when doctors’ lies about normal childhood immaturity being a genetic “brain illness” became accepted. Here are some statistics that support my argument that psychiatry is the root cause of our heroin epidemic.

Tripping for Knowledge: The Psychedelic Epistemologist

5
In this interview for 3:AM Magazine, Chris Letheby argues that even though psychedelics may induce delusions or imaginary phenomena, their use can also lead to accurate...